(S)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D4 Antagonist

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medicinal chemistry 1996-06, Vol.39 (13), p.2435-2437
Hauptverfasser:	TenBrink, Ruth E, Bergh, Carol L, Duncan, J. Neil, Harris, Douglas W, Huff, R. M, Lahti, Robert A, Lawson, Charles F, Lutzke, Barry S, Martin, Iain J, Rees, Susan A, Schlachter, Siusaidh K, Sih, John C, Smith, Martin W
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antipsychotic Agents - chemical synthesis Antipsychotic Agents - chemistry Antipsychotic Agents - metabolism Antipsychotic Agents - pharmacology Biological and medical sciences Biological Availability Catecholaminergic system CHO Cells Cricetinae Dopamine Agonists - pharmacology Dopamine Antagonists - chemical synthesis Dopamine Antagonists - chemistry Dopamine Antagonists - metabolism Dopamine Antagonists - pharmacology Dopamine D2 Receptor Antagonists Ergolines - antagonists & inhibitors Humans Medical sciences Molecular Structure Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology. Drug treatments Piperazines - chemical synthesis Piperazines - chemistry Piperazines - metabolism Piperazines - pharmacology Protein Binding Quinpirole Receptors, Adrenergic - metabolism Receptors, Dopamine D4 Receptors, Serotonin - metabolism Schizophrenia - drug therapy Sulfonamides - chemical synthesis Sulfonamides - chemistry Sulfonamides - metabolism Sulfonamides - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!